Canada Pension Plan Investment Board Apellis Pharmaceuticals, Inc. Transaction History

Canada Pension Plan Investment Board

  • $98.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$37.14 - $64.82 $1.2 Million - $2.1 Million
-32,400 Reduced 39.37%
49,900 $2.99 Million
Q3 2022

Nov 14, 2022
SELL
$44.76 - $69.66 $308,844 - $480,654
-6,900 Reduced 7.74%
82,300 $5.62 Million
Q2 2022

Aug 12, 2022
BUY
$35.07 - $59.21 $3.13 Million - $5.28 Million
89,200 New
89,200 $4.03 Million

Others Institutions Holding APLS

# of Institutions
310
Shares Held
113M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.29B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email